Driven to Challenge
the Status Quo
Our purpose is to accelerate the transition to bioalternatives by delivering the benefits of synthetic biology, today.
Augusta BioFacility
Replicating Nature.
Delivering Scale.
Unleashing the Potential
With cell factories, everyday complex molecules can be produced locally, reliably, and sustainably, using a combination of synthetic biology and precision fermentation. We are focused on unleashing this potential for the benefit of industry, society, and our planet.
Bridging the Valley of Death
Despite SynBio’s potential benefits, it is still difficult to commercialize these molecules. We are dedicated to helping companies bridge the Valley between the lab and manufacturing scale to ensure promising molecules achieve commercial success.
Delivering the Benefits
We have developed a revolutionary cell factory engineering platform to achieve technical scale-up for any process. Our proven track record with multiple commercialized products demonstrates our capability of bridging the Valley of Death faster and more reliably than anyone else. That is how we are accelerating the transition to bioalternatives and delivering the benefits of synthetic biology, today.
Our roots:
Taking a hands-on approach
to synthetic biology
Born out of MIT, our company was founded on the belief that cell factories can be engineered to be radically more productive and efficient at producing complex molecules than plants. But without the ability to scale, the technology would never fulfill its promise.
Manus operates under the mantra that scale is imperative: We can continuously accelerate the optimization of biocatalysts to perform complex chemistries at scale.
Manus embodies the real-world application of ideas from the founding team of Dr. Aji Parayil, Dr. Greg Stephanopoulos, and a group of biochemical engineers at MIT who saw the opportunity to address critical gaps in the sustainable sourcing of chemicals and ingredients using biotechnology. Dr. Stephanopoulos, a renowned MIT chemical engineering professor, pioneered the field of metabolic engineering three decades ago and set the stage for developing innovative cell factories that perform novel chemistries. Dr. Parayil and his team expanded on this foundation to industrialize and scale the production of a diverse range of complex, plant-based natural products.
The Latin word “manus” means “hand.” To us, this symbolizes the practical application of these ideas developed at MIT and reflects our commitment to hands-on innovation. “Manus” is also the root word of “manufacturing,” representing our focus on scale, product delivery – and real impact.
Our BioFacility in
Boston, Massachusetts
Our Boston BioFacility is a leading biotech R&D hub, home to top scientists in cell factory engineering and cutting-edge research, driving innovation towards more sustainable solutions and a bioalternative future.
Quantitative analytical characterization
in our Boston BioFacility
Scientists in our Boston BioFacility
Cell factory engineering at our Boston BioFacility
Our BioFacility in
Augusta, Georgia
Our BioFacility in Augusta is a prominent biotech operation, firmly committed to pioneering sustainable solutions and supporting scale-up through our unique biomanufacturing capabilities.
Our Augusta large-scale BioFacility
BioFacility manager in Augusta, Georgia
Our Purpose Drives Us
We exist to accelerate the transition to
bioalternatives by delivering the benefits of synthetic biology, today.
Our Principles Guide Us
At Manus, we are guided by a set of core principles that define our mission and approach to biotechnology. These principles drive our commitment to ethical practices, scientific excellence, and innovation.
Challenge the Status Quo
01
Accelerating the transition of complex molecules to bioalternatives.
Collaborate for Impact
02
Working with value chain partners to successfully commercialize bioalternatives at scale.
Deliver on Promises
03
Getting the job done, delivering the performance and sustainability benefits of synthetic biology.
Our Character Grounds Us
Our character is the foundation of our biotech mission, driving our commitment to ethics, innovation, and positive impact.
Passionate
01
Excited about the potential of what we do, challenging each other, and pushing limits.
Systematic
02
Data and insight-driven, working diligently to be as efficient as possible in everything we do.
Determined
03
Moving fast, looking beyond traditional thinking to find practical solutions to achieving our goals.
Our Chairman of the Board and Senior Leadership Team